Esophagitis induced by combined radiation and adriamycin

With the increasing use of combined chemotherapy and radiotherapy in the treatment of certain types of malignancy, a clinically distinct type of esophagitis has been recognized as an undesirable side effect. It occurs with low doses (less than 2,000 rad) of mediastinal radiation in patients who simultaneously or sequentially receive either adriamycin or actinomycin D. Characteristic of this entity is "recall": recurrent episodes of esophagitis with each course of chemotherapy. The radiographic findings are nonspecific, ranging from subtle alterations in motility to severe damage with irreversible stricture formation. The primary differential diagnostic considerations are infectious processes. The radiographic spectrum, clinical aspects, and differential diagnoses in five patients are discussed.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J Cadranel, D Garfield, A Lavole, M Wislez, B Milleron, and C Mayaud Lung cancer in HIV infected patients: facts, questions and challenges. Thorax, November 1, 2006; 61(11): 1000 - 1008. [Abstract] [Full Text] [PDF]

				P. Luedtke, M. S. Levine, S. E. Rubesin, D. S. Weinstein, and I. Laufer Radiologic Diagnosis of Benign Esophageal Strictures: A Pattern Approach RadioGraphics, July 1, 2003; 23(4): 897 - 909. [Abstract] [Full Text] [PDF]

				L. Maggiorella, V. Frascogna, M.-G. Poullain, M. Berlion, C. Lucas, S. Douc Razy, F. Eschwege, and J. Bourhis The Olivacine S16020 Enhances the Antitumor Effect of Ionizing Radiation without Increasing Radio-induced Mucositis Clin. Cancer Res., July 1, 2001; 7(7): 2091 - 2095. [Abstract] [Full Text] [PDF]